News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
OccuLogix Inc.’ POC Diagnostics Subsidiary, OcuSense, Achieves ISO 13485:2003 Certification
April 9, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO, CALIFORNIA--(Marketwire - April 08, 2008) - OccuLogix, Inc. (NASDAQ: OCCX)(TSX: OC) announced today that its point-of-care diagnostics subsidiary, OcuSense, Inc., has received company-wide certification to ISO 13485:2003.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
August 14, 2025
·
3 min read
·
Annalee Armstrong
Tariffs
Trump Tarries on Tariffs Again, Delays Plans by Weeks: Report
August 14, 2025
·
2 min read
·
Tristan Manalac
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
August 14, 2025
·
1 min read
·
Lori Ellis
Podcast
Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues
August 13, 2025
·
2 min read
·
Heather McKenzie
